Geron | GERN - Ordinary Share Capital


Geron reported $638.36M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Amgen USD 539M 1000K Dec/2025
Bio Techne USD 155.75M 154.18M Sep/2025
Cassava Sciences USD 48.31M 0 Dec/2025
Cytokinetics USD 122.26M 145K Dec/2025
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Exelixis USD 268.1M 2.03M Sep/2025
Genmab DKK 61.62M 52K Dec/2025
Geron USD 638.36M 338K Dec/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
MacroGenics USD 63.32M 60K Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Novavax USD 162.58M 106K Dec/2025